You can buy or sell BioCryst and other stocks, options, ETFs, and crypto commission-free!
BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include rapivab, alpivab, rapiacta, peramiflu, BCX7353, BCX9930, BCX9250, Galidesivir, and Mundesine. Read More The company was founded in 1986 and is headquartered in Durham, NC.
Durham, North Carolina
52 Week High
52 Week Low
-$0.34 per share